Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2026-05-25 Director's Dealing
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Comunicato Internal Dealing
Director's Dealing Classification · 92% confidence The document is an insider trading notification (“Comunicato Internal Dealing”) pursuant to EU Market Abuse Regulation, detailing a transaction by a person discharging managerial responsibilities. It is clearly a report of a director’s/share option transaction by an insider, matching the Director’s Dealing category.
2026-05-25 Italian
Comunicato Internal Dealing
Director's Dealing Classification · 95% confidence The document is a notification under EU Market Abuse Regulation of a transaction by a person exercising management functions (assignment of stock options to an executive), including detailed insider transaction data (price, volume, instrument, date). This corresponds to a Director’s Dealing / insider trade report, not a broader financial report or a mere announcement. Therefore, it is classified as DIRS.
2026-05-25 Italian
Comunicato Internal Dealing
Director's Dealing Classification · 93% confidence The document is a formal Internal Dealing disclosure under EU MAR rules (Regulation (EU) No 596/2014). It provides details of a transaction by a Relevant Person (Amelia Parente), including instrument type, volume, price, date, and trading venue. This matches the definition of Director’s Dealing (insider/management share transactions) rather than an earnings release or regulatory report.
2026-05-25 Italian
Comunicato Internal Dealing
Director's Dealing Classification · 98% confidence The document is a detailed notification of transactions by a person discharging managerial responsibilities (“comunicazione al pubblico delle operazioni effettuate da persone che esercitano funzioni di amministrazione…”), specifying insider stock option assignments. This matches the definition of Director’s Dealing (insider trades) filings.
2026-05-25 Italian
Report on the treasury shares buy-back plan of Diasorin S.p.A. – Period 18/05/2026 – 22/05/2026
Regulatory Filings
2026-05-22 Italian
Informativa sul programma di acquisto di azioni proprie di Diasorin S.p.A. - Periodo 18/05/2026 – 22/5/2026
Regulatory Filings
2026-05-22 Italian

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.